Javascript is not activated in your browser. This website needs javascript activated to work properly.
Du är här

Drosophila melanogaster deoxyribonucleoside kinase activates gemcitabine

  • Wolfgang Knecht
  • Nils Egil Mikkelsen
  • Anders Ranegaard Clausen
  • Mette Willer
  • Hans Eklund
  • Zoran Gojkovic
  • Jure Piskur (Professor)
Publiceringsår: 2009
Språk: Engelska
Sidor: 430-433
Publikation/Tidskrift/Serie: Biochemical And Biophysical Research Communications
Volym: 382
Nummer: 2
Dokumenttyp: Artikel
Förlag: Academic Press Inc Elsevier Science


Drosophila melanogaster multisubstrate deoxyribonucleoside kinase (Dm-dNK) can additionally sensitize human cancer cell lines towards the anti-cancer drug gemcitabine. We show that this property is based on the Dm-dNK ability to efficiently phosphorylate gemcitabine. The 2.2 angstrom resolution structure of DmdNK in complex with gemcitabine shows that the residues Tyr70 and Arg105 play a crucial role in the firm positioning of gemcitabine by extra interactions made by the fluoride atoms. This explains why gemcitabine is a good substrate for Dm-dNK(. (C) 2009 Elsevier Inc. All rights reserved.



  • Medicine and Health Sciences
  • Structure-function relationship
  • Salvage pathway
  • Cancer
  • Gene-therapy
  • Nucleoside analogs
  • Deoxyribonucleoside kinase


  • ISSN: 0006-291X

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen